| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/07/2008 | US20080032932 Method of reducing mortality and morbidity associated with critical illnesses |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080031965 Oral Preparations and Process for Production Thereof |
| 02/07/2008 | US20080031955 Product Comprising a Beta-Lactam Antibiotic |
| 02/07/2008 | US20080031941 Gastric acid secretion inhibiting composition |
| 02/07/2008 | US20080031936 Immunostimulatory nucleic acid molecules |
| 02/07/2008 | US20080031931 Organotellurium and selenium-based antimicrobial formulations and articles |
| 02/07/2008 | US20080031907 Cosmetic and pharmaceutical foam |
| 02/07/2008 | US20080031903 Method of treating ocular infections |
| 02/07/2008 | US20080031895 Influenza virus-like particle (VLP) compositions |
| 02/07/2008 | US20080031890 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 02/07/2008 | US20080031889 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 02/07/2008 | US20080031887 Conjugates for inducing targeted immune responses and methods of making and using same |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031872 HIV immunogenic composition and method of administration |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides |
| 02/07/2008 | US20080031852 inhibitor of HCV NS5B polymerase; to treat infections caused by hepatitis C virus; 3-(1,1-Dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methyl-butyl)-pyrrolo[1,2-b]pyridazin-2-one |
| 02/07/2008 | CA2660120A1 Agent for preventing infection |
| 02/07/2008 | CA2659697A1 Method of proliferating lak cell |
| 02/07/2008 | CA2659391A1 Antibiotic composition |
| 02/07/2008 | CA2658479A1 Novel hiv reverse transcriptase inhibitors |
| 02/07/2008 | CA2658446A1 Antiviral use of cationic surfactant |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/06/2008 | EP1884520A2 Daptomycin analogs as antibacterial agents |
| 02/06/2008 | EP1883641A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
| 02/06/2008 | EP1883633A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 02/06/2008 | EP1883452A2 Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1883304A1 Process for treating animal waste |
| 02/06/2008 | EP1697515A4 Dna-carrier conjugate |
| 02/06/2008 | EP1682076A4 Inhibitors of coronavirus protease and methods of use thereof |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101120018A Human monoclonal antibody specific for lipopolysaccharides (LPS) of the pseudomonas aeruginosa IATS O11 serotype |
| 02/06/2008 | CN101120011A Macrolides |
| 02/06/2008 | CN101120004A 8a,9-dihydro-4ah-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 02/06/2008 | CN101120001A 12位取代姆替林衍生物 12 to replace Tim triptyline derivatives |
| 02/06/2008 | CN101119976A HIV inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 02/06/2008 | CN101119971A Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same |
| 02/06/2008 | CN101117336A 7-(4-oxime-3-amino-1-piperidine) quinoline carboxylic acid derivative and method for making same |
| 02/06/2008 | CN101117328A Fatty acid synthetase inhibitor and application for treating bacterial infection |
| 02/06/2008 | CN101116750A Canine adenovirus DNA vaccines pVAX1-CpG-Loop |
| 02/06/2008 | CN101116749A Swine fever replicon carrier vaccines, the method for preparing the same and application thereof |
| 02/06/2008 | CN101116744A Combination neisserial compositions |
| 02/06/2008 | CN101116743A Cold treating medicine |
| 02/06/2008 | CN101116739A Chinese traditional medicine for treating acute and chronic hepatitis |
| 02/06/2008 | CN101116733A Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis |
| 02/06/2008 | CN101116714A Chinese medicine preparation for treating infectious molluscum |
| 02/06/2008 | CN101116690A Chinese patent drug for treating acquired immuno-deficiency syndrome |
| 02/06/2008 | CN101116670A Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis |
| 02/06/2008 | CN101116662A Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation |
| 02/06/2008 | CN101116656A Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
| 02/06/2008 | CN100366633C Antiviral polypeptide from Zongdian Tuanwa frog and its application in pharmacy |
| 02/06/2008 | CN100366624C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles |
| 02/06/2008 | CN100366621C Plumepoppy total alkaloid salt and its prepn and application |
| 02/06/2008 | CN100366292C Recombinant porcine adenovirus vector |
| 02/06/2008 | CN100366291C O, A type bivalent inactivated vaccine for foot-and-mouth disease of ruminant as cattle and sheep |
| 02/06/2008 | CN100366282C Medicinal compositions comprising biphenyldicarboxylate |
| 02/06/2008 | CN100366281C Chinese medicinal composition for treating fuberculosis |
| 02/06/2008 | CN100366265C Chinese traditional medicine for treating AIDS |
| 02/06/2008 | CN100366262C A medicine for treating dermatosis, venereal diseases, cancer and AIDS and preparation method thereof |
| 02/06/2008 | CN100366259C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 02/06/2008 | CN100366244C Local used composition containing antifungal agent |
| 02/06/2008 | CN100366238C Freeze dried polyene lecithin powder for injection and its prepn |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326695 Anti-bacterial agents based upon oxoanion binding |
| 02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326541 Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2395204C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 02/05/2008 | CA2339272C Nitrogen-containing heterocyclic carboxamide derivatives or salts thereof and antiviral agents comprising the same |
| 02/05/2008 | CA2281642C Substituted 2,4-diaminopyrimidines |
| 02/05/2008 | CA2278140C Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/05/2008 | CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 01/31/2008 | WO2008014431A2 Method of treating ocular infections |
| 01/31/2008 | WO2008014311A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 01/31/2008 | WO2008014307A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 01/31/2008 | WO2008014221A2 Bridged carbamate macrolides |
| 01/31/2008 | WO2008014108A2 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | WO2008013834A1 Bisfuranyl protease inhibitors |
| 01/31/2008 | WO2008013334A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same |
| 01/31/2008 | WO2008013242A1 Method for production of n36-binding peptide |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008012310A1 Caspofungin formulations |
| 01/31/2008 | WO2008011980A1 Preparation of antimicrobial formulations using 7-oxa-2-thia-1,5-diazabicyclo[3.3.1]nonane-2,2-dione |
| 01/31/2008 | WO2008011752A2 Drugs for resisting bacteria, viruses, cancers, tumors, irritabilities and defects |
| 01/31/2008 | WO2007126392A8 Antimicrobial peptides |
| 01/31/2008 | WO2006110814A3 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027213 Chimeric immunogens |